Laser treatment in the management of infantile hemangiomas and capillary vascular malformations.

Abstract

Vascular lesions encountered in dermatology can be divided into vascular malformations and vascular tumors, namely infantile hemangiomas (IH). Vascular malformations can further be subdivided by their flow characteristics and vessel type. Slow, or low-flow lesions are either capillary vascular malformations (CVMs), venous malformations, or lymphatic malformations. Fast, or high-flow lesions include an arterial component, and are categorized as arteriovenous malformations. IH and CVMs are among the most common benign vascular lesions seen and treated in dermatology. CVMs are present at birth and grow as the individual does, whereas IH usually appear days to weeks later and may rapidly enlarge for a period of months to a year before gradually involuting. As the technology has evolved, early and often laser treatment with the pulsed dye 595-nm laser has become our standard therapy of choice. More recently, we have started more patients on combination therapy for IH with the topical beta blocker timolol. If left untreated, CVMs darken and thicken, making them increasingly difficult to successfully treat with lasers. IH involute, sometimes resulting in fibrofatty, atrophic plaques. These individuals can undergo ablative fractional resurfacing with a fractional CO2 laser to improve the texture and appearance of these lesions.

• Authors: Jeremy A Brauer, Roy G Geronemus
• Journal: Techniques in vascular and interventional radiology (Tech Vasc Interv Radiol) Vol. 16 Issue 1 Pg. 51-4 (Mar 2013) ISSN: 1557-9808 [Electronic] United States
• PMID: 23499132 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2013 Elsevier Inc. All rights reserved.

Topics

• Hemangioma (surgery)
• Humans
• Infant
• Infant, Newborn
• Lasers, Dye (therapeutic use)
• Vascular Malformations (surgery)